BNP Paribas Asset Management’s Lifestance Health LFST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.22M Buy
394,118
+108
+0% +$835 ﹤0.01% 941
2026
Q1
$2.51M Buy
394,010
+13,759
+4% +$95.7K ﹤0.01% 1030
2025
Q4
$2.68M Buy
380,251
+379,275
+38,860% +$2.29M ﹤0.01% 1005
2025
Q3
$5K Sell
976
-271
-22% -$1.33K ﹤0.01% 1830
2025
Q2
$6K Buy
+1,247
New +$7.47K ﹤0.01% 1940

Other funds holding LFST

BNP Paribas Asset Management's LFST Position: Q2 2026 in Review

BNP Paribas Asset Management increased its Lifestance Health (LFST) stake by 0.03% in Q2 2026, buying an estimated $835 and bringing the position to 394,118 shares worth $4.22M. The position accounts for ﹤0.01% of the portfolio, ranked #941.

BNP Paribas Asset Management first reported a position in LFST in Q2 2025 and has held it in 5 quarters since. 288 funds tracked by Wall St. Rank hold LFST as of Q2 2026.

  • BNP Paribas Asset Management held 394,118 shares of Lifestance Health worth $4.22M as of Q2 2026.
  • BNP Paribas Asset Management bought 108 Lifestance Health shares in Q2 2026, an estimated $835.
  • Lifestance Health made up ﹤0.01% of BNP Paribas Asset Management's portfolio in Q2 2026, its #941 holding.
  • BNP Paribas Asset Management first reported a position in Lifestance Health in Q2 2025 and has held it in 5 quarters since.
  • 288 funds tracked by Wall St. Rank held Lifestance Health as of Q2 2026.

Based on BNP Paribas Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.